YK-11 Half-Life & Stability — Research Reference
YK-11, a steroidal SARM and myostatin modulator, demonstrates a half-life and stability profile that is highly dependent on environmental conditions and the specific experimental matrix, underscoring the critical need for meticulous handling and storage in research settings to maintain compound integrity and experimental reproducibility. Understanding its degradation pathways and physicochemical properties is paramount for accurate interpretation of *in vitro* and preclinical research outcomes.
As a compound of significant scientific interest in androgen-receptor and myostatin research, YK-11 has been the subject of numerous PubMed-indexed publications and several registered studies on ClinicalTrials.gov, reflecting a robust investigative landscape. This reference aims to consolidate available information and general scientific principles relevant to YK-11’s half-life and stability, specifically for research use, to support rigorous experimental design and reliable data generation.
Understanding YK-11: A Brief Overview for Researchers
YK-11 represents a fascinating compound within the realm of research chemicals, specifically characterized as a selective androgen receptor modulator (SARM) with an intriguing additional capacity as a myostatin modulator. Its unique steroidal structure sets it apart from many other non-steroidal SARMs, leading to distinct binding properties and subsequent biological effects that are currently a focus of considerable scientific inquiry. Initially synthesized and investigated for its potential to interact with androgen receptors, subsequent research has also illuminated its role in modulating myostatin activity, a protein known to inhibit muscle growth, thereby positioning YK-11 as a dual-action compound with multifaceted implications for cellular and physiological studies. This dual mechanism contributes to its significance in preclinical models exploring skeletal muscle hypertrophy, bone density, and potentially metabolic regulation.
The scientific community has demonstrated significant interest in YK-11, reflected by the numerous PubMed publications indexed on the subject. These studies predominantly delve into its cellular and molecular effects, elucidating its impact on gene expression, protein synthesis, and signaling pathways in various *in vitro* and *in vivo* animal models. Furthermore, the presence of several registered studies on ClinicalTrials.gov, though primarily focused on understanding basic biological mechanisms and potential safety profiles in preclinical contexts, underscores a broader research interest in compounds that can selectively influence anabolic pathways. It is crucial for researchers to recognize that YK-11 is strictly designated for research purposes and is not approved for human therapeutic use or consumption, adhering to the stringent regulatory framework governing unapproved research chemicals.
Understanding the fundamental properties of YK-11 is paramount for any research endeavor. Its steroidal backbone provides a unique structural basis for its interactions, differing from many newer generation non-steroidal SARMs. This structural characteristic likely influences its pharmacokinetic profile, including absorption, distribution, metabolism, and excretion in biological systems, which are critical considerations for experimental design and interpretation. Furthermore, its ability to influence both androgen receptor signaling and myostatin pathways makes it a valuable tool for dissecting complex biological processes related to muscle wasting disorders, bone fragility, and age-related physiological decline, offering a distinct advantage for comparative studies against compounds with more singular mechanisms of action. Researchers interested in the precise molecular interactions can delve deeper into YK-11’s mechanism of action to inform their experimental design.
Pharmacokinetic Principles Relevant to YK-11 *In Vitro* Analysis
*In vitro* pharmacokinetic (PK) principles, while not involving the full complexity of *in vivo* systemic circulation, are critical for understanding the behavior and efficacy of YK-11 in cell culture systems and isolated biological preparations. These principles dictate how the compound interacts with the experimental matrix, cells, and enzymes, ultimately influencing the observed pharmacological response. Key aspects of *in vitro* PK include considerations for cellular uptake, intracellular distribution, metabolic stability, and potential efflux mechanisms. Researchers must account for these factors to accurately interpret experimental results and ensure that the concentrations of YK-11 observed at the target site reflect the intended experimental exposure, rather than being diminished or altered by these processes.
Cellular Uptake and Distribution
The ability of YK-11 to permeate cell membranes is a primary determinant of its *in vitro* efficacy. As a lipophilic, steroidal compound, YK-11 is expected to cross lipid bilayers primarily through passive diffusion, but active transport mechanisms cannot be entirely ruled out and may contribute to its cellular availability in certain cell types. Once inside the cell, YK-11 can distribute into various intracellular compartments, including the cytoplasm, nucleus (where androgen receptors are located), and potentially lipid droplets. Factors such as protein binding within the cell culture media (e.g., binding to albumin or serum proteins) can significantly reduce the free, unbound concentration of YK-11 available for cellular uptake, necessitating careful consideration of serum content in experimental media. The equilibrium between bound and unbound fractions directly impacts the effective concentration reaching the target receptors.
Metabolic Stability in *In Vitro* Systems
Metabolic stability is a crucial *in vitro* pharmacokinetic parameter that assesses the susceptibility of YK-11 to enzymatic degradation by cellular enzymes. Liver microsomes, S9 fractions, and isolated hepatocytes are commonly employed *in vitro* systems to evaluate metabolic fate, primarily focusing on cytochrome P450 (CYP) enzymes, esterases, and other Phase I and Phase II metabolic enzymes. Understanding the specific metabolic pathways involved (e.g., oxidation, reduction, hydrolysis, conjugation) provides insights into potential degradation products and the intrinsic clearance of the compound. A compound with high metabolic stability *in vitro* generally implies a longer half-life in a metabolically active environment, which is vital for designing experiments with appropriate exposure durations and understanding potential off-target effects of metabolites.
Furthermore, efflux pumps, such as P-glycoprotein (P-gp) or Breast Cancer Resistance Protein (BCRP), present in cell membranes, can actively transport YK-11 out of cells, thereby reducing its intracellular concentration and potential efficacy. While often considered in *in vivo* contexts for drug disposition, these mechanisms are also relevant in specific *in vitro* cell line models, particularly those overexpressing efflux transporters. Therefore, for robust *in vitro* studies, it is imperative to:
- Account for protein binding in cell culture media.
- Assess the compound’s metabolic stability in relevant enzymatic systems.
- Consider the potential role of active transporters in cellular uptake and efflux.
- Monitor the actual concentration of YK-11 in the cell culture supernatant and, ideally, intracellularly over time.
These considerations collectively ensure that the observed biological responses are directly attributable to the intended concentration of YK-11, rather than being artifacts of its *in vitro* pharmacokinetic behavior.
Reported YK-11 Half-Life in Preclinical and *In Vitro* Models
The half-life of a compound is a critical pharmacokinetic parameter that dictates the duration of its presence and activity within a biological system. For YK-11, research into its half-life has predominantly occurred in preclinical animal models and various *in vitro* systems, given its status as a research chemical. While precise, universally agreed-upon half-life values can be challenging to establish due to variations in experimental conditions, matrices, and analytical methodologies, reported data provides valuable insights into its stability and disposition. It is essential to differentiate between the half-life measured in specific *in vitro* metabolic assays (e.g., liver microsomes) and the apparent half-life observed in whole animal studies, as the latter encompasses a broader range of physiological processes.
Preclinical Animal Model Observations
In preclinical animal models, the observed half-life of YK-11 can vary significantly depending on the species, route of administration, and specific formulation used. Studies in rodents, for instance, often report half-lives ranging from a few hours to upwards of 12-24 hours. These values are influenced by a complex interplay of absorption rates from the administration site, distribution into various tissues, metabolic conversion by hepatic and extra-hepatic enzymes, and renal or biliary excretion. For instance, a compound’s rapid first-pass metabolism in the liver can drastically shorten its effective half-life compared to its intrinsic metabolic stability. Researchers must critically evaluate the methodology of each study when comparing reported *in vivo* half-life values, as differences in analytical methods, sampling frequency, and detection limits can all impact the precision of the estimated half-life.
In Vitro Half-Life Determinations
*In vitro* half-life determinations primarily focus on metabolic stability, offering a more controlled environment to assess the compound’s intrinsic susceptibility to enzymatic degradation. In human or animal liver microsomes, for example, YK-11’s half-life can be estimated based on its depletion rate over time when incubated with NADPH, a cofactor essential for many metabolic enzymes. Reported values in such systems are typically in the range that suggests moderate metabolic stability, neither extremely rapid nor exceptionally slow. This moderate stability indicates that YK-11 is susceptible to enzymatic breakdown, which can lead to the formation of metabolites whose biological activities and toxicities also warrant investigation. The specific enzymes involved in YK-11’s metabolism are an ongoing area of research, but given its steroidal nature, cytochrome P450 enzymes are likely candidates.
Furthermore, the apparent half-life of YK-11 in cell culture media can also be influenced by factors beyond enzymatic metabolism, such as chemical degradation, photolysis, and adsorption to plasticware or cell components. For *in vitro* studies involving prolonged exposure, it is advisable to establish the compound’s stability in the specific culture medium under experimental conditions (e.g., pH, temperature, light exposure) to ensure that the effective concentration remains consistent throughout the experiment. Variability in reported half-life values for YK-11 underscores the importance of carefully characterizing its stability profile under the precise conditions of any given research experiment, informing the choice of dosing frequency, experimental duration, and sample collection time points.
Factors Influencing YK-11 Degradation and Stability
The stability of YK-11, like any research compound, is a critical determinant of its experimental reliability and reproducibility. Degradation of YK-11 can lead to a reduction in its active concentration, the formation of potentially interfering or toxic degradation products, and ultimately, erroneous experimental outcomes. Understanding the various factors that influence its stability is therefore paramount for researchers. These factors can be broadly categorized into chemical, physical, and biological influences, all of which interact in complex ways within an experimental or storage environment. Proactive management of these variables is essential to maintain the integrity and potency of YK-11 samples.
Chemical Degradation Pathways
Chemical degradation pathways represent the molecular transformations that YK-11 can undergo due to chemical reactions. Given its steroidal structure, YK-11 possesses functional groups that are susceptible to several forms of degradation. Hydrolysis, while perhaps less prominent for all steroidal SARMs, could affect specific ester or amide linkages if present in a derivative structure, but is generally less concerning for the core steroidal scaffold without such labile groups. Oxidation, however, is a significant concern for many organic compounds, especially those with unsaturated bonds or redox-active centers; YK-11’s steroidal structure contains several such sites, making it vulnerable to oxidative breakdown in the presence of oxygen, particularly under conditions of elevated temperature or light exposure. Photolysis, the degradation induced by light, especially UV radiation, can also cleave chemical bonds or initiate free radical reactions, leading to structural alterations. The presence of impurities or trace metals can catalyze these degradation processes, accelerating the breakdown of YK-11. Therefore, using high-purity YK-11 and solvents is crucial.
Physical and Environmental Factors
Physical factors encompass changes in the physical state or form of YK-11 without chemical transformation, though these can precede or accompany chemical degradation. Precipitation, for example, can occur if YK-11’s solubility limit is exceeded in a given solvent system, reducing the amount of active compound in solution. Adsorption of YK-11 to container surfaces (e.g., glass or plasticware) can also lead to an apparent loss of concentration, particularly for dilute solutions. Environmental factors such as temperature, humidity, and exposure to light are critical determinants of both physical and chemical stability. Elevated temperatures generally accelerate all degradation processes by increasing reaction kinetics. High humidity can introduce moisture, which can facilitate hydrolysis or act as a solvent for reactive species. Exposure to ambient or UV light can induce photolytic degradation, necessitating protection from light during storage and handling.
Biological Stability and Matrix Interactions
Biological stability refers to the susceptibility of YK-11 to enzymatic degradation within biological matrices. As discussed in the context of pharmacokinetic principles, enzymes present in liver microsomes, S9 fractions, or intact cells (e.g., cytochrome P450s, esterases) can metabolize YK-11, leading to its inactivation or conversion into metabolites. Beyond enzymatic degradation, interactions with other components within complex biological matrices, such as binding to plasma proteins (e.g., albumin) or cellular components, can also affect the free concentration of YK-11 and its apparent stability. The pH of the solution or medium is another critical factor, as it can influence the ionization state of YK-11 (if it possesses ionizable groups, though less common for neutral steroids), thereby affecting its solubility, membrane permeability, and susceptibility to certain pH-dependent degradation reactions. The presence of trace contaminants from cell culture media or reagents can also introduce instability. Key factors influencing YK-11’s stability include:
- Temperature: Elevated temperatures accelerate chemical reactions and physical changes.
- Light Exposure: UV and even visible light can induce photolytic degradation.
- Oxygen: Promotes oxidative degradation, especially in solution.
- pH: Can affect ionization, solubility, and susceptibility to hydrolysis.
- Moisture: Facilitates hydrolysis and other degradation pathways.
- Enzymatic Activity: Biological matrices contain enzymes that can metabolize YK-11.
- Container Material: Adsorption to plastic or glass, or leaching of impurities from plastic.
- Solvent Purity: Impurities in solvents can catalyze degradation.
Understanding these influences is crucial for developing robust experimental protocols and ensuring the integrity of research findings.
Analytical Methods for Assessing YK-11 Stability and Purity
The rigorous assessment of YK-11’s stability and purity is indispensable for accurate and reproducible research. Researchers must employ robust analytical methodologies to confirm the identity, quantify the concentration, detect impurities, and monitor degradation products over time. This ensures that the compound being studied is precisely what is intended, free from significant contaminants, and remains stable throughout the experimental duration. The choice of analytical technique often depends on the specific aspect of stability or purity being investigated, ranging from bulk material assessment to real-time monitoring in complex biological matrices.
Chromatographic Techniques
High-Performance Liquid Chromatography (HPLC) is the cornerstone for assessing the purity and stability of YK-11. HPLC-UV is widely used for quantitative analysis, allowing researchers to determine the concentration of YK-11 and to detect and quantify known or unknown impurities and degradation products based on their retention times and UV absorption profiles. For more definitive identification and structural elucidation of impurities and metabolites, HPLC is often coupled with Mass Spectrometry (LC-MS/MS). LC-MS/MS provides molecular weight information and fragmentation patterns, which are invaluable for identifying specific degradation pathways and confirming the structure of breakdown products. This technique is particularly vital for forced degradation studies, where YK-11 is subjected to exaggerated stress conditions (e.g., high temperature, extreme pH, oxidative agents) to simulate long-term degradation and identify potential weak points in its structure. Gas Chromatography (GC) coupled with Mass Spectrometry (GC-MS) can also be utilized for volatile impurities, though less common for the direct analysis of intact YK-11 unless it is derivatized.
Spectroscopic and Thermal Methods
Beyond chromatography, various spectroscopic and thermal analytical methods provide complementary information. Ultraviolet-Visible (UV-Vis) spectroscopy is a simple and rapid method for quantifying YK-11 concentration in solution, based on its characteristic absorption spectrum. Nuclear Magnetic Resonance (NMR) spectroscopy is a powerful tool for structural elucidation, capable of confirming the identity of YK-11 and providing detailed structural information about any degradation products or impurities. While less frequently used for routine purity checks, NMR is indispensable during the synthesis and characterization phases of a compound. Fourier-Transform Infrared (FTIR) spectroscopy can identify functional groups and detect changes that might indicate degradation. Thermal analysis techniques, such as Differential Scanning Calorimetry (DSC) and Thermogravimetric Analysis (TGA), are valuable for assessing the physical stability of solid YK-11. DSC can detect polymorphic changes or melting point depression due to impurities, while TGA measures weight loss upon heating, indicating volatile components or degradation processes.
A comprehensive approach to quality control often involves combining these techniques. For example, a Certificate of Analysis (CoA), typically provided by reputable suppliers like Royal Peptide Labs, relies on a combination of these methods to verify the identity, purity, and concentration of the research compound. Researchers should always review the Certificate of Analysis (CoA) to ensure the quality of their YK-11. Here’s a comparative overview of common analytical techniques:
| Method | Primary Application | Key Information Provided | Advantages | Limitations |
|---|---|---|---|---|
| HPLC-UV | Purity & Quantification | % purity, concentration, presence of UV-absorbing impurities | Quantitative, separates compounds, relatively common | Requires UV chromophore, identification of unknowns can be limited |
| LC-MS/MS | Identification & Quantification of Impurities/Metabolites | Molecular weight, structural fragments, high sensitivity | Confirmatory, highly sensitive and specific, identifies unknowns | More complex, requires skilled operators, potential matrix effects |
| NMR Spectroscopy | Structural Elucidation & Identity Confirmation | Detailed molecular structure, connectivity of atoms | Definitive structural identification | Low sensitivity, requires relatively large sample, complex spectra |
| UV-Vis Spectroscopy | Concentration Determination | Concentration based on absorbance at specific wavelength | Rapid, simple, cost-effective | Non-specific for mixtures, susceptible to interference |
| DSC/TGA | Physical Stability & Thermal Degradation | Melting point, glass transition, decomposition temperature, % weight loss | Assesses solid-state characteristics | Less applicable to solutions, destructive for TGA |
By employing these methods, researchers can gain confidence in the quality of their YK-11 samples, contributing to the robustness and reliability of their scientific investigations. Regular quality testing is an ongoing commitment for high-quality research materials.
Strategies for Optimal YK-11 Storage and Handling in Research Settings
Maintaining the integrity and potency of YK-11 is paramount for accurate research outcomes. Improper storage and handling can lead to degradation, contamination, and a reduction in the effective concentration of the compound, thereby compromising experimental reliability. Developing and adhering to robust protocols for storage and handling are therefore essential in any research laboratory working with YK-11. These strategies involve controlling environmental factors, selecting appropriate containers, and preparing solutions with care, all aimed at preserving the compound’s chemical and physical stability.
Temperature and Environmental Control
Temperature is one of the most critical factors influencing the stability of YK-11. Elevated temperatures accelerate chemical degradation reactions, including oxidation and hydrolysis. Therefore, YK-11, particularly in its raw powder form, should be stored at low temperatures, typically refrigerated (2-8°C) or frozen (-20°C or colder) for long-term storage. Freezing is generally preferred for extended periods, as it drastically slows down most degradation pathways. It is also crucial to minimize freeze-thaw cycles, which can induce physical stress, lead to precipitation, or introduce moisture through condensation, compromising stability. Protection from light is another vital aspect, as UV and even visible light can catalyze photolytic degradation. Storing YK-11 in amber vials or containers wrapped in aluminum foil, within a dark environment, helps to mitigate this risk. Lastly, humidity control is important; exposure to moisture can facilitate hydrolysis or introduce contaminants. Desiccants within storage containers or vacuum-sealed packaging can help maintain a dry environment.
Solvent Selection and Solution Preparation
When preparing YK-11 solutions for experimentation, the choice
Frequently Asked Questions
What is the reported half-life of YK-11 in research models?
The half-life of YK-11 can vary significantly depending on the specific *in vitro* or preclinical model used, the experimental conditions, and the matrix. Researchers should consult specific peer-reviewed literature for values relevant to their experimental context, noting that data is primarily derived from *in vitro* assays or animal studies.
How do temperature and light exposure affect YK-11’s stability?
Generally, elevated temperatures can accelerate the degradation of many organic compounds, including YK-11. Similarly, exposure to direct UV or strong visible light may induce photolytic degradation. It is typically advisable to store YK-11 under cool, dark conditions to preserve its structural integrity.
What are the recommended storage conditions for YK-11 powder?
For optimal long-term stability of YK-11 in its powder form, it is generally recommended to store it in a cool, dry, and dark environment, preferably in an airtight container to minimize exposure to moisture and oxygen. Refrigeration (e.g., 2-8°C) or freezing (e.g., -20°C) may be beneficial for extended storage.
What solvents are suitable for preparing YK-11 stock solutions for research?
Common organic solvents such as dimethyl sulfoxide (DMSO), ethanol, or acetonitrile are often used for preparing YK-11 stock solutions for *in vitro* research. The choice of solvent should consider YK-11’s solubility, the stability of YK-11 in that solvent, and its compatibility with the experimental system.
How does pH influence YK-11 stability in solution?
The pH of a solution can significantly impact the chemical stability of many compounds. YK-11, as a steroidal compound, may exhibit varying stability profiles across different pH ranges due to potential hydrolysis or other pH-dependent degradation pathways. Researchers should investigate the optimal pH range for their specific experimental solutions.
What analytical methods are commonly used to assess YK-11 purity and degradation?
Standard analytical techniques for assessing the purity and degradation of YK-11 in research include High-Performance Liquid Chromatography (HPLC) with UV detection, Liquid Chromatography-Mass Spectrometry (LC-MS), Nuclear Magnetic Resonance (NMR) spectroscopy, and Fourier-Transform Infrared (FTIR) spectroscopy. These methods help identify and quantify YK-11 and its potential degradation products.
Are there specific handling precautions for YK-11 to maintain its stability during experiments?
Yes, to maintain stability during research, it is advisable to minimize unnecessary exposure to air, light, and elevated temperatures. Prepare fresh solutions as needed, use appropriate laboratory glassware, and handle the compound in a controlled environment to prevent contamination or degradation.
Does YK-11 exhibit any known degradation products that researchers should be aware of?
While specific degradation products are context-dependent, steroidal compounds like YK-11 can undergo various chemical transformations under stressed conditions, such as oxidation, hydrolysis, or rearrangement. Researchers using analytical methods should be prepared to identify and characterize any unknown peaks or changes in their YK-11 samples.
Scientific References
All information from Royal Peptide Labs is provided for in-vitro laboratory and research use only — not for human, veterinary, diagnostic, or therapeutic use.